Friday, December 13

Healthcare

Roth starts CG Oncology at purchase, cites anticipated FDA filing

08/29/20241 Min Read

anticipated buy cites FDA filing Oncology Roth starts

Previous ArticleENDRA Life Sciences granted extension to regain compliance with Nasdaq continued listing requirements

Next Article Palatin stock climbs 8% on Phase 3 testing update for PL9643